A liposomal amphotericin B injection [Amphocil; Samaritan Pharmaceuticals Europe] has received approval in Cyprus, for invasive aspergillosis

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1615, 2007-01, pp. : 23-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Amphotericin B formulations in invasive aspergillosis

By  

Inpharma, Vol. 1, Iss. 1355, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Liposomal Amphotericin and Caspofungin: Salvage Therapy for Invasive Aspergillosis in Hepatic Failure

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 38, Iss. 3, 2008-09 ,pp. : 223-225

John Wiley & Sons Inc

Access to resources Recommend Favorite

Liposomal Amphotericin B: A Review of its Use as Empirical Therapy in Febrile Neutropenia and in the Treatment of Invasive Fungal Infections

By Moen Marit D.   Lyseng-Williamson Katherine A.   Scott Lesley J.  

Drugs, Vol. 69, Iss. 3, 2009-02 ,pp. : 361-392

Adis International

Access to resources Recommend Favorite

Voriconazole cost effective vs amphotericin B for aspergillosis

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 497, 2006-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Post-Approval Changes in Pharmaceuticals: Regulatory Perspectives in Europe

By  

Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 2, Iss. 2, 2015-08 ,pp. : 60-68

Bentham Science Publishers

Access to resources Recommend Favorite